NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/03/2025
Back to search
Official data from USPTO
WAVELENGTH ALWAYS ALIGNED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000087707343Class
1, 5, 35, 40, 42
Filing
87707343
Registration
5542748
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
01/03/2025
Trademark type
Combined
Nice classes
1, 5, 35, 40, 42
Filing date
12/04/2017
Registration date
08/14/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/03/2025
Last transaction
01/03/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/30/2018
First use in commerce
05/30/2018
Drawing code
3
Owner type
99
Owner location
New York, NY
Examiner
PENDLETON, CAROLYN
Current location
Historical data usage
Mark description
The mark consists of wave inside a square followed by the literal elements "wavelength always aligned" appearing on two lines.
Holders and representatives
Holders
WaveLength Pharmaceuticals Ltd
Representatives
Kevin C. Parks Leydig, Voit & Mayer, Ltd.
Technical classification
Nice Classes
Class 1Class 5Class 35Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical intermediates and active chemical ingredients for use in the manufacturing of pharmaceuticals
Class 5
Pharmaceutical preparations for the treatment of allergiesthrombosisAlzheimer's diseaseinflammationnauseaepilepsydepressionhypertensionnasal constrictionParkinson's diseasepain and inflammationneuro-muscular diseaseasthmanarcolepsyneoplasmleukemiavaginal infections
Class 35
Providing advertisingmarketing and promotional services in the field of pharmaceuticals
Class 40
Custom manufacture of pharmaceuticals by pharmaceutical compounders
Class 42
Pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
23 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/03/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/02/2025
E815
TEAS SECTION 8 & 15 RECEIVED
08/02/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/14/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/14/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/11/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/10/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/20/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/20/2018
IUAF
USE AMENDMENT FILED
05/30/2018
EISU
TEAS STATEMENT OF USE RECEIVED
05/30/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/10/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/13/2018
PUBO
PUBLISHED FOR OPPOSITION
02/13/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/24/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2018
DOCK
ASSIGNED TO EXAMINER
01/04/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/14/2017
NWAP
NEW APPLICATION ENTERED
12/07/2017
Continuous trademark protection
Get notified about every new filing that threatens WAVELENGTH ALWAYS ALIGNED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.